Article
The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population.
Transplantation proceedings - 1 Jan 2000
Krüger B, Walberer A, Farkas S, Tokmak F, Obed A, Schenker P, Henning B, Schlitt H J, Krämer B K, Banas B
Abstract excerpt
BACKGROUND: At present, inflammation is considered to be one of the key players in the development and maintenance of atherosclerosis, with ample impact on renal transplant outcomes. Interleukin-6 (IL-6) levels and the underlying genetically determined "high-producer" status impact cardiovascular morbidity and mortality. In end-stage renal disease (ESRD) patients, the role of genetically determined IL-6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
